Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

被引:0
|
作者
Van der Heide, M. [1 ]
Verstraelen, T. E. [1 ]
Van Lint, F. H. M. [2 ]
Bosman, L. P. [3 ]
De Brouwer, R. [4 ]
Proost, V. M. [1 ]
Abeln, G. S. [1 ]
Schoonderwoerd, B. A. [5 ]
Houweling, A. C. [2 ]
Gimeno-Blanes, J. R. [6 ]
Asselbergs, F. W. [3 ]
De Boer, R. A. [4 ]
Van den Berg, M. P. [4 ]
Van Tintelen, J. P. [2 ]
Wilde, A. A. M. [1 ]
机构
[1] Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Clin Genet, Amsterdam, Netherlands
[3] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands
[4] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[5] Med Ctr Leeuwarden, Dept Cardiol, Leeuwarden, Netherlands
[6] Virgen Arrixaca Univ Hosp, Dept Cardiol, Murcia, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:673 / 673
页数:1
相关论文
共 50 条
  • [21] Histopathological Characterization of Phospholamban p.Arg14del Mutation-Related Cardiomyopathy in Relation to Clinical Presentation
    te Rijdt, Wouter P.
    Gho, Johannes M.
    van der Zwaag, Paul A.
    de Boer, Rudolf A.
    van den Berg, Maarten A.
    van Tintelen, J. P.
    van der Wal, Allard C.
    Vink, Aryan
    Suurmeijer, Albert J.
    CIRCULATION, 2013, 128 (22)
  • [22] Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Badone, Beatrice
    Ronchi, Carlotta
    Lodola, Francesco
    Knaust, Anika E.
    Hansen, Arne
    Eschenhagen, Thomas
    Zaza, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [23] The Phospholamban p.Arg14del Mutation-Related Cardiomyopathy Is an Arrhythmogenic Cardiomyopathy and Protein Aggregation Disease
    te Rijdt, W. P.
    van der Zwaag, P.
    van den Berg, M. P.
    van Tintelen, P.
    Suurmeijer, A. J.
    LABORATORY INVESTIGATION, 2014, 94 : 94A - 94A
  • [24] Phospholamban p.arg14del Mutation in a Spanish Family With Arrhythmogenic Cardiomyopathy: Evidence for a European Founder Mutation
    Maria Lopez-Ayala, Jose
    Boven, Ludolf
    van den Wijngaard, Arthur
    Penafiel-Verdu, Pablo
    van Tintelen, Johan Peter
    Ramon Gimeno, Juan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (04): : 346 - 349
  • [25] Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
    van der Zwaag, P. A.
    van Rijsingen, I. A. W.
    de Ruiter, R.
    Nannenberg, E. A.
    Groeneweg, J. A.
    Post, J. G.
    Hauer, R. N. W.
    van Gelder, I. C.
    van den Berg, M. P.
    van der Harst, P.
    Wilde, A. A. M.
    van Tintelen, J. P.
    NETHERLANDS HEART JOURNAL, 2013, 21 (06) : 286 - 293
  • [26] Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study
    van der Heide, Myrthe Y. C.
    Verstraelen, Tom E.
    van Lint, Freyja H. M.
    Bosman, Laurens P.
    de Brouwer, Remco
    Proost, Virginnio M.
    van Drie, Esmee
    Taha, Karim
    Zwinderman, Aeilko H.
    Dickhoff, Cathelijne
    Schoonderwoerd, Bas A.
    Germans, Tjeerd
    Houweling, Arjan C.
    Gimeno-Blanes, Juan R.
    van der Zwaag, Paul A.
    de Boer, Rudolf A.
    Cox, Moniek G. P. J.
    van Tintelen, J. Peter
    Wilde, Arthur A. M.
    EUROPACE, 2024, 26 (04):
  • [27] Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy
    Eijgenraam, T. R.
    Stege, N. M.
    Teixeira, V. Oliveira Nunes
    Beverborg, N. Grote
    Spaeter, D.
    Knoell, R.
    Hansson, K. M.
    Amilon, C.
    Janzen, D.
    Yeh, S. T.
    Mullick, A. E.
    Van der Meer, P.
    De Boer, R. A.
    Sillje, H. H. W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 277 - 277
  • [28] Cardiac contractility modulation as bailout in a patient with phospholamban p.Arg14del related cardiomyopathy intolerant to medication: a case report
    Verelst, Faro R.
    Van Assche, Lauranne
    Huybrechts, Wim
    Gevaert, Andreas B.
    Van Craenenbroeck, Emeline M.
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2025, 9 (01)
  • [29] INCREMENTAL VALUE OF RIGHT VENTRICULAR ENDOMYOCARDIAL BIOPSY TO THE PHENOTYPING OF PHOSPHOLAMBAN P.ARG14DEL MUTATION-RELATED CARDIOMYOPATHY
    te Rijdt, Wouter P.
    van der Zwaag, Paul A.
    de Boer, Rudolf
    Van den Berg, Maarten
    van Tintelen, J. Peter
    Suurmeijer, Albert J. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A933 - A933
  • [30] A novel mouse model of phospholamban p.Arg14del cardiomyopathy develops heart failure with protein aggregation and is unresponsive to common heart failure drugs
    Eijgenraam, T. R. Tim Ruben
    Boukens, B. J.
    Schouten, E. M.
    Van De Kolk, C. W. A.
    Stege, N. M.
    Van Den Berg, M. P.
    Van Der Meer, P.
    Sillje, H. H. W.
    De Boer, R. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 264 - 264